Search - tctmd.com

Displaying 441 - 460 of 766

Sort: Relevancy | Date

News Daily News

Stent Malapposition Frequent, But Without Clinical Consequences

Jason Kahn

January 27, 2014

News Daily News

La Mala Aposición del Stent es algo Frecuente que No tiene Consecuencias Clínicas

Jason Kahn

January 27, 2014

News Daily News

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

January 22, 2014

News Daily News

‘Simple’ Approach to Repeat PCI Safe, Successful at 4 Years in Unprotected LM Disease

Leah Lawrence

January 22, 2014

News Daily News

老年患者接受CABG或DES的疗效及安全性相似

Yael L. Maxwell

January 15, 2014

News Daily News

Similares Resultados de Seguridad con CABG y SLF en Pacientes Ancianos

Yael L. Maxwell

January 15, 2014

News Daily News

Similar Safety Outcomes with CABG, DES in Elderly Patients

Yael L. Maxwell

January 15, 2014

News Industry News

ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease

January 13, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Yael L. Maxwell

January 09, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Meta-analysis: CABG Bests PCI for Long-term Morbidity, Mortality in Multivessel CAD

Yael L. Maxwell

December 30, 2013

News Daily News

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

December 30, 2013

News Daily News

Second-Generation DES the Better Choice for STEMI Patients

December 09, 2013

News Daily News

IVUS Guidance Reduces Stent Thrombosis, MACE Compared to Angiography

December 08, 2013

News Industry News

Alvimedica merges with CID, Italy's leading high tech company specialized in cardiology

November 19, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

News Industry News

Study Examines the Impact of Insulin Treatment Status in Diabetic Patients with Multivessel Coronary Artery Disease

October 31, 2013

News Industry News

New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated With a Second Generation Drug-Eluting Stent

October 31, 2013

News Conference News TCT 2013

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

October 31, 2013

Advertisement

Stent Malapposition Frequent, But Without Clinical Consequences

La Mala Aposición del Stent es algo Frecuente que No tiene Consecuencias Clínicas

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

‘Simple’ Approach to Repeat PCI Safe, Successful at 4 Years in Unprotected LM Disease

老年患者接受CABG或DES的疗效及安全性相似

Similares Resultados de Seguridad con CABG y SLF en Pacientes Ancianos

Similar Safety Outcomes with CABG, DES in Elderly Patients

ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Meta-analysis: CABG Bests PCI for Long-term Morbidity, Mortality in Multivessel CAD

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

Second-Generation DES the Better Choice for STEMI Patients

IVUS Guidance Reduces Stent Thrombosis, MACE Compared to Angiography

Alvimedica merges with CID, Italy's leading high tech company specialized in cardiology

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

Study Examines the Impact of Insulin Treatment Status in Diabetic Patients with Multivessel Coronary Artery Disease

New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated With a Second Generation Drug-Eluting Stent

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content